Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-04

Clinical Trial Update: Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)

View source ↗

Summary

A clinical trial update from the University of Vienna regarding chromosomal damage in patients with type 2 diabetes, with cancer also listed among conditions; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Vienna | Conditions: Type 2 Diabetes, Cancer | Status: UNKNOWN